Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Shaughnessy

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Blood|November 16, 2002
A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcriptMadhumita Santra, Fenghuang Zhan, Erming Tian, et al.
Blood|March 29, 2003
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiationKarin Tarte, Fenghuang Zhan, John De Vos, et al.
British Journal of Haematology|March 4, 2006
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survivalYun Ge, Fenghuang Zhan, Bart Barlogie, et al.
Blood|October 24, 2002
Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell developmentFenghuang Zhan, Erming Tian, Klaus Bumm, et al.
Blood|March 10, 2005
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaP Leif Bergsagel, W Michael Kuehl, Fenghuang Zhan, et al.
British Journal of Haematology|June 17, 2004
Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myelomaJames Peter Stewart, Alexander Thompson, Madhumita Santra, et al.
Blood|September 13, 2003
Treatment of multiple myelomaBart Barlogie, John Shaughnessy, Guido Tricot, et al.
Statistical Applications in Genetics and Molecular Biology|May 2, 2006
Evaluation of multiple models to distinguish closely related forms of disease using DNA microarray data: an application to multiple myelomaJohanna Hardin, Michael Waddell, C David Page, et al.
Blood|March 1, 2003
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survivalKai-Da Wu, Lisa M Orme, John Shaughnessy, et al.
Genes, Chromosomes & Cancer|October 9, 2004
Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1qJeffrey R Sawyer, Guido Tricot, Janet L Lukacs, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Blood|November 16, 2002
A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcriptMadhumita Santra, Fenghuang Zhan, Erming Tian, et al.
Blood|March 29, 2003
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiationKarin Tarte, Fenghuang Zhan, John De Vos, et al.
British Journal of Haematology|March 4, 2006
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survivalYun Ge, Fenghuang Zhan, Bart Barlogie, et al.
Blood|October 24, 2002
Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell developmentFenghuang Zhan, Erming Tian, Klaus Bumm, et al.
Blood|March 10, 2005
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaP Leif Bergsagel, W Michael Kuehl, Fenghuang Zhan, et al.
British Journal of Haematology|June 17, 2004
Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myelomaJames Peter Stewart, Alexander Thompson, Madhumita Santra, et al.
Blood|September 13, 2003
Treatment of multiple myelomaBart Barlogie, John Shaughnessy, Guido Tricot, et al.
Statistical Applications in Genetics and Molecular Biology|May 2, 2006
Evaluation of multiple models to distinguish closely related forms of disease using DNA microarray data: an application to multiple myelomaJohanna Hardin, Michael Waddell, C David Page, et al.
Blood|March 1, 2003
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survivalKai-Da Wu, Lisa M Orme, John Shaughnessy, et al.
Genes, Chromosomes & Cancer|October 9, 2004
Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1qJeffrey R Sawyer, Guido Tricot, Janet L Lukacs, et al.
Pageof 6